a clear trendgold
Nevertheless, this difference was not persistent for disease control rate at 3 months with 86.7% response in group B versus 61.1% in group A ( p = 0.15), nor at 6 months with 77.8% for group B versus 33.3% for group A, despite a clear trend for a better efficacy of personalized treatment.